Topic: Blood Clots And Embolisms
ADELPHI, Maryland (Reuters) - U.S. drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch be simplified to better explain the risk of blood clots.In a 20 to 3 vote with one abstention, advisers to the Food ...
A panel of experts that advises the US Food and Drug Administration has urged stronger labeling on birth control pills such as Bayer's Yaz that have a shown a higher risk of blot clots.Results of the 21-5 vote released late Thursday showed ...
ADELPHI, Maryland (Reuters) - U.S. health advisers recommended a revision of labels for the widely used new generation of birth control pills, based on data showing they may put women at a higher risk of dangerous blood clots.Although all common birth control ...
ADELPHI, Maryland (Reuters) - U.S. health advisers recommended a revision of labels for the widely used new generation of birth control pills, based on data showing they may put women at a higher risk of dangerous blood clots.Although all common birth control ...
WASHINGTON (Reuters) - Health officials are weighing stricter labels on the widely used new generation of birth control pills, based on data showing they may put women at a higher risk of dangerous blood clots.U.S. Food and Drug Administration staff reviewed studies ...
NEW YORK (Reuters Health) - Hormone-targeted therapy for prostate cancer may raise the risk of potentially dangerous blood clots, a large U.S. study suggests.Analyzing data on more than 154,000 older men with prostate cancer, researchers found that those who received hormonal therapy ...
NEW YORK (Reuters Health) - A study out Monday adds to evidence that a newer type of birth control pill may carry a higher risk of blood clots than older versions.The study, of 330,000 Israeli women, found that those who used birth ...
Some birth control products, including contraceptive pills, rings and patches for women, carry a significantly higher risk of blood clot than low-dose medications, US regulators said Thursday.The US Food and Drug Administration said in its review of studies that have included more ...
US regulators said Tuesday that Xarelto, a Bayer-made drug approved in July for preventing blood clots, is so far unproven for a new proposed use as a stroke preventer."There is a lack of substantial evidence that rivaroxaban will have its desired effect ...
NEW YORK (Reuters Health) - A new study adds to evidence that skin patches offer a safer alternative to pills for women who want to treat their menopausal symptoms with hormones.The study, of 54,000 women who used hormone replacement therapy (HRT), found ...